Overview
Maren Kaufmann practices in Braunschweig, Germany. Ms. Kaufmann is rated as an Advanced expert by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Adult T-Cell Leukemia, Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), and Leukemia.
Her clinical research consists of co-authoring 37 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 13 articles in the study of Acute Lymphoblastic Leukemia (ALL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Lymphoblastic Leukemia (ALL)Ms. Kaufmann isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adult T-Cell LeukemiaMs. Kaufmann isAdvanced. Learn about Adult T-Cell Leukemia.
- Hodgkin LymphomaMs. Kaufmann isAdvanced. Learn about Hodgkin Lymphoma.
- Experienced
- Anaplastic Large Cell LymphomaMs. Kaufmann isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Angelman SyndromeMs. Kaufmann isExperienced. Learn about Angelman Syndrome.
- B-Cell LymphomaMs. Kaufmann isExperienced. Learn about B-Cell Lymphoma.
- Burkitt LymphomaMs. Kaufmann isExperienced. Learn about Burkitt Lymphoma.
- Cutaneous T-Cell Lymphoma (CTCL)Ms. Kaufmann isExperienced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Follicular LymphomaMs. Kaufmann isExperienced. Learn about Follicular Lymphoma.